Used primarily in scientific research to study the prostacyclin (IP) receptor pathway, RO1138452 acts as a potent and selective antagonist. It helps investigators understand the role of prostacyclin signaling in processes such as vasodilation, platelet aggregation, and inflammation. Due to its selectivity, it is valuable in experiments aiming to isolate IP receptor activity from other prostanoid receptors. It has been applied in cardiovascular research to explore mechanisms of blood pressure regulation and thrombosis. Additionally, it serves as a pharmacological tool in studies examining pain perception and endothelial function. Not intended for therapeutic use or human application.